Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Contreras

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Journal of Virology|July 27, 2018
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in MiceFlavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
The Journal of Biological Chemistry|May 24, 2014
Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteinsHeidi Contreras, Matthew S Joens, Lisa M McMath, et al.
Research Square|July 24, 2020
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
NPJ Vaccines|January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Nature Communications|December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|August 17, 2017
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in miceFlavia Chiuppesi, Felix Wussow, Louise Scharf, et al.
Journal of Virology|July 27, 2018
Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in MiceFlavia Chiuppesi, Jenny Nguyen, Soojin Park, et al.
The Journal of Biological Chemistry|May 24, 2014
Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteinsHeidi Contreras, Matthew S Joens, Lisa M McMath, et al.
Research Square|July 24, 2020
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
NPJ Vaccines|January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Nature Communications|December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 2